Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Kneidl
Secukinumab Is Superior to Fumaric Acid Esters in Treating Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to Systemic Treatments: Results From the Randomized Controlled PRIME Trial
British Journal of Dermatology
Dermatology
Medicine
Related publications
A 24‐week Multicentre, Randomised, Open‐label, Parallel‐group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate‐to‐severe Plaque Psoriasis Naïve to Systemic Treatment
British Journal of Dermatology
Dermatology
Medicine
Fumaric Acid Esters in Combination With a 6-Week Course of Narrowband Ultraviolet B Provides an Accelerated Response Compared With Fumaric Acid Esters Monotherapy in Patients With Moderate-To-Severe Plaque Psoriasis: A Randomized Prospective Clinical Stud
British Journal of Dermatology
Dermatology
Medicine
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Comparability of Trial Populations in Network Meta-Analyses Assessing Biologic Treatments in Moderate to Severe Plaque Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Effect of Secukinumab on Moderate-To-Severe Scalp Psoriasis: Results of a 24-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3b Study
Journal of the American Academy of Dermatology
Dermatology
Pss31 - Cost Per Responder of Secukinumab Compared to Other Biologics in Moderate-To-Severe Plaque Psoriasis From the Private Payer Perspective in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients With Moderate-To-Severe Plaque Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
